Published by MBA Skool Team, Last Updated: August 20, 2021
SWOT analysis of GlaxoSmithKline analyses the brand by its strengths, weaknesses, opportunities & threats. In GlaxoSmithKline SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.
SWOT Analysis is a proven management framework which enables a brand like GlaxoSmithKline to benchmark its business & performance as compared to the competitors. GlaxoSmithKline is one of the leading brands in the pharma and healthcare sector.
The article below lists the GlaxoSmithKline SWOT (Strengths, Weaknesses, Opportunities, Threats), top GlaxoSmithKline competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).
For GlaxoSmithKline, SWOT analysis can help the brand focus on building upon its strengths and opportunities while addressing its weaknesses as well as threats to improve its market position. Let us start the GlaxoSmithKline SWOT Analysis:
The strengths of GlaxoSmithKline looks at the key aspects of its business which gives it competitive advantage in the market. Some important factors in a brand's strengths include its financial position, experienced workforce, product uniqueness & intangible assets like brand value. Below are the Strengths in the SWOT Analysis of GlaxoSmithKline :
1. GSK is one of the top 5 largest pharmaceutical companies.
2.GSK is one of the world’s largest investor in R&D and UK's biggest private sector funder of R&D.
3. Winner of chemical industry manufacturing and resource efficiency award.
4. Strong R&D focus and exploring new markets
5. GSK is a global presence is in over 100 countries
6. Has a strength of over 97000 employees
The weaknesses of a brand are certain aspects of its business which are it can improve to increase its position further. Certain weaknesses can be defined as attributes which the company is lacking or in which the competitors are better. Here are the weaknesses in the GlaxoSmithKline SWOT Analysis:
1. Controversies regarding issue of safety of drugs affects company’s image
2. Patent expiry for a number of bulk-buster products
The opportunities for any brand can include areas of improvement to increase its business. A brand's opportunities can lie in geographic expansion, product improvements, better communication etc. Following are the opportunities in GlaxoSmithKline SWOT Analysis:
1.Strategic agreements with other pharmaceutical companies and organizations to boost its research.
2. Increasing awareness about healthcare needs 3. Global penetration through mergers and acquisitions
4. Increasing demand for quality healthcare solutions
The threats for any business can be factors which can negatively impact its business. Some factors like increased competitor activity, changing government policies, alternate products or services etc. can be threats. The threats in the SWOT Analysis of GlaxoSmithKline are as mentioned:
1.Risk of unsuccessful new Products
2.Regulatory environment is becoming more & more stringent
3.Economic slowdown in European markets
There are several brands in the market which are competing for the same set of customers. Below are the top 10 competitors of GlaxoSmithKline:
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to GlaxoSmithKline. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way. Edit the brand or add a new one to SWOT Analysis section : Contribute